alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Federal Register Volume 75, Number 45 (Tuesday, March 9, 2010)]
[Notices]
[Page 10845]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4936]

-----------------------------------------------------------------------

 SMALL BUSINESS ADMINISTRATION

[Disaster Declaration  12034 and  12035]

Arkansas Disaster Number AR-00042

AGENCY: U.S. Small Business Administration.

ACTION: Amendment 1.

-----------------------------------------------------------------------

SUMMARY: This is an amendment of the Presidential declaration of a 
major disaster for Public Assistance Only for the State of Arkansas 
(FEMA-1872-DR), dated 02/04/2010.
    Incident: Severe Storms and Flooding.
    Incident Period: 12/23/2009 through 01/02/2010.

Effective Date: 02/26/2010.
    Physical Loan Application Deadline Date: 04/05/2010.
    Economic Injury (EIDL) Loan Application Deadline Date: 11/04/2010.

ADDRESSES: Submit completed loan applications to: U.S. Small Business 
Administration, Processing and Disbursement Center, 14925 Kingsport 
Road, Fort Worth, TX 76155.

FOR FURTHER INFORMATION CONTACT: A. Escobar, Office of Disaster 
Assistance, U.S. Small Business Administration, 409 3rd Street, SW., 
Suite 6050, Washington, DC 20416.

SUPPLEMENTARY INFORMATION: The notice of the President's major disaster 
declaration for Private Non-Profit organizations in the State of 
Arkansas, dated 02/04/2010, is hereby amended to include the following 
areas as adversely affected by the disaster.

Primary Counties: Pulaski

    All other information in the original declaration remains 
unchanged.

(Catalog of Federal Domestic Assistance Numbers 59002 and 59008)

James E. Rivera,
Associate Administrator for Disaster Assistance.
[FR Doc. 2010-4936 Filed 3-8-10; 8:45 am]
BILLING CODE 8025-01-P
```
<TABLE> <S> <C>

<ARTICLE> 9
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
REGISTRANT'S FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARCH 31, 1999 AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                          15,550
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                27,500
<TRADING-ASSETS>                                   117
<INVESTMENTS-HELD-FOR-SALE>                      1,760
<INVESTMENTS-CARRYING>                          44,976
<INVESTMENTS-MARKET>                            44,958
<LOANS>                                        210,218
<ALLOWANCE>                                      3,355
<TOTAL-ASSETS>                                 308,277
<DEPOSITS>                                     272,294
<SHORT-TERM>                                     5,672
<LIABILITIES-OTHER>                              2,882
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           711
<OTHER-SE>                                      26,718
<TOTAL-LIABILITIES-AND-EQUITY>                 308,277
<INTEREST-LOAN>                                  4,883
<INTEREST-INVEST>                                  666
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                                 5,794
<INTEREST-DEPOSIT>                               1,504
<INTEREST-EXPENSE>                               1,584
<INTEREST-INCOME-NET>                            4,210
<LOAN-LOSSES>                                      300
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                  4,651
<INCOME-PRETAX>                                    186
<INCOME-PRE-EXTRAORDINARY>                         140
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       140
<EPS-PRIMARY>                                      .20
<EPS-DILUTED>                                      .20
<YIELD-ACTUAL>                                    5.98
<LOANS-NON>                                      3,623
<LOANS-PAST>                                       138
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                 3,296
<CHARGE-OFFS>                                      253
<RECOVERIES>                                        12
<ALLOWANCE-CLOSE>                                3,355
<ALLOWANCE-DOMESTIC>                             3,355
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                            669
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                6-MOS
<FISCAL-YEAR-END>                    DEC-31-1999
<PERIOD-END>                         Jun-30-1999
<CASH>                                   37,479
<SECURITIES>                                  0
<RECEIVABLES>                          2,306,366
<ALLOWANCES>                             56,549
<INVENTORY>                            1,809,536
<CURRENT-ASSETS>                       5,533,553
<PP&E>                                 9,626,186
<DEPRECIATION>                         7,452,221
<TOTAL-ASSETS>                        8,083,565
<CURRENT-LIABILITIES>                 3,724,966
<BONDS>                                5,963,244
<PREFERRED-MANDATORY>                         0
<PREFERRED>                                   0
<COMMON>                                     414
<OTHER-SE>                           (8,609,701)
<TOTAL-LIABILITY-AND-EQUITY>          8,083,565
<SALES>                               7,078,638
<TOTAL-REVENUES>                       7,078,638
<CGS>                                 6,569,906
<TOTAL-COSTS>                          6,569,906
<OTHER-EXPENSES>                      1,043,023
<LOSS-PROVISION>                              0
<INTEREST-EXPENSE>                       271,099
<INCOME-PRETAX>                        (819,742)
<INCOME-TAX>                                  0
<INCOME-CONTINUING>                    (819,742)
<DISCONTINUED>                                0
<EXTRAORDINARY>                               0
<CHANGES>                                     0
<NET-INCOME>                          (819,742)
<EPS-BASIC>                             (0.02)
<EPS-DILUTED>                             (0.02)


</TABLE>
<TABLE> <S> <C>


<ARTICLE>                     5
                       
<MULTIPLIER>                   1,000
<CURRENCY>                     U.S. Dollars           
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>               JUN-30-1997          
<PERIOD-START>                  JUL-01-1996    
<PERIOD-END>                    SEP-30-1996    
<EXCHANGE-RATE>                            1    
<CASH>                                    32   
<SECURITIES>                               0   
<RECEIVABLES>                          2,609   
<ALLOWANCES>                             173        
<INVENTORY>                            9,163   
<CURRENT-ASSETS>                      12,040   
<PP&E>                                10,163   
<DEPRECIATION>                         3,370   
<TOTAL-ASSETS>                        20,236   
<CURRENT-LIABILITIES>                  6,836   
<BONDS>                                    0   
<PREFERRED-MANDATORY>                      0   
<PREFERRED>                                0   
<COMMON>                                   3   
<OTHER-SE>                             6,413   
<TOTAL-LIABILITY-AND-EQUITY>          20,236   
<SALES>                               16,161   
<TOTAL-REVENUES>                      16,161   
<CGS>                                 10,355   
<TOTAL-COSTS>                         16,284   
<OTHER-EXPENSES>                           0   
<LOSS-PROVISION>                           0   
<INTEREST-EXPENSE>                       160   
<INCOME-PRETAX>                         (283)   
<INCOME-TAX>                            (119)  
<INCOME-CONTINUING>                     (283)  
<DISCONTINUED>                             0  
<EXTRAORDINARY>                            0   
<CHANGES>                                  0   
<NET-INCOME>                            (164)   
<EPS-PRIMARY>                           (.06)  
<EPS-DILUTED>                           (.06)  
        

</TABLE>
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 08-6880

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

v.

LARRY BEVERLY GARLAND,

Defendant - Appellant.

Appeal from the United States District Court for the Eastern

District of Virginia, at Richmond. Henry E. Hudson, District

Judge. (3:05-cr-00263-HEH)

Submitted: August 21, 2008 Decided: August 27, 2008

Before WILLIAMS, Chief Judge, and KING and DUNCAN, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Larry Beverly Garland, Appellant Pro Se. Angela Mastandrea-Miller,

Assistant United States Attorney, Richmond, Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit.
 2 

PER CURIAM:

Larry Beverly Garland appeals the district court’s order

denying his motion filed under 18 U.S.C. § 3582(c)(2) (2000). We

have reviewed the record and find no reversible error.

Accordingly, we affirm for the reasons stated by the district

court. United States v. Garland, No. 3:05-cr-00263-HEH (E.D. Va.

Apr. 21, 2008). We dispense with oral argument because the facts

and legal contentions are adequately presented in the materials

before the court and argument would not aid the decisional process.

AFFIRMED
Editorial Note on Part 872
Editorial Note: Nomenclature changes to part 872 appear at 73 FR 35341, June 23, 2008.

§ 872.3250 Calcium hydroxide cavity liner. ( a ) *Identification.* A calcium hydroxide cavity liner is a device material intended to be applied to the interior of a prepared cavity before insertion of restorative material, such as amalgam, to protect the pulp of a tooth.
( b ) *Classification.* Class II.
Exhibit 99.1

                               CIT RV TRUST 1999-A
                          ANNUAL OFFICER'S CERTIFICATE

                            COMPLIANCE WITH AGREEMENT

      The undersigned certifies that he is a Vice President of The CIT
Group/Sales Financing, Inc., a corporation organized under the laws of the state
of Delaware ("CITSF"), and that as such he is duly authorized to execute and
deliver this certificate on behalf of CITSF in connection with Section 4.10 (a)
of the Sale and Servicing Agreement, dated as of May 1, 1999 (the "Agreement"),
among CITSF, The CIT Group Securitization Corporation II, as Seller, and CIT RV
Trust 1999-A, for which The Bank of New York acts as Owner Trustee and FMB Bank
acts as Indenture Trustee (all capitalized terms used herein without definition
having the respective meanings specified in the Agreement). The undersigned
further certifies to the Owner Trustee and to the Indenture Trustee that a
review of the activities of CITSF during the preceding calendar year and of its
performance under the Agreement has been made under his supervision and to the
best of his knowledge, based on such review, CITSF has fulfilled its obligations
under the Agreement during the preceding calendar year.

      IN WITNESS WHEREOF, I have affixed hereto my signature this 31st day of
March, 2000.

                                               /s/ Frank Garcia
                                        --------------------------------
                                        Name:  Frank Garcia
                                        Title: Vice President
Editorial Note on Part 878
Editorial Note: Nomenclature changes to part 878 appear at 73 FR 35341, June 23, 2008.

§ 878.4018 Hydrophilic wound dressing. ( a ) *Identification.* A hydrophilic wound dressing is a sterile or non-sterile device intended to cover a wound and to absorb exudate. It consists of nonresorbable materials with hydrophilic properties that are capable of absorbing exudate (e.g., cotton, cotton derivatives, alginates, dextran, and rayon). This classification does not include a hydrophilic wound dressing that contains added drugs such as antimicrobial agents, added biologics such as growth factors, or is composed of materials derived from animal sources.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in part 807, subpart E of this chapter subject to the limitations in § 878.9.
[64 FR 53929, Oct. 5, 1999]
**UN PUBLISHED** 

UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 14** 
**- 7536** 

WILLIAM E. SMITH ,
Plaintiff

- Appellant ,

v.

CORRECTIONAL OFFICER BERLIN; CORRECTIONAL OFFICER MARCUM; CORRECTIONAL OFFICER BLANKENSHIP; CORRECTIONAL OFFICER GOODWIN; CORRECTIONAL OFFICER VANMETER; CORRECTIONAL OFFICER LAMBERT; MICHAEL CLARK ,
Defendants

- Appellees ,
and

WEST VIRGINIA REGIONAL JAIL & CORRECTIONAL FACILITY AUTHORITY; SOUTHWESTERN REGIONAL JAIL; CORRECTIONAL OFFICER BLEVINS; CORRECTIONAL O FFICER TOOTAL; CORRECTIONAL OFFICER JANE DOE,

Defendants

.

Appeal from the United States District Court for the Southern District of West Virginia , at Huntington

. Robert C. Chambers , Chief District Judge. ( 3:12

- cv

- 07358 )

Submitted : January 22, 2015 Decided: January 27, 2015

Before SHEDD, KEENAN, and DIAZ , Circuit Judges.

Dismissed by un published per curiam opinion

.2 William E. Smith, Appellant Pro Se. Tim J. Yianne, MANNION GRAY, Charleston, West Virginia; John P. Fuller, James William Marshall, III, BAILEY & WYANT, PLLC, Charleston, West Virginia, for Appellees.

Unpublished opinions are not binding precedent in this circuit.3 PER CURIAM:

William E. Smith seeks to appeal the district court’s
order granting partial summary judgment to Appellees on his 42

U.S.C. § 1983 (2012) suit . This court may exercise jurisdiction
only over final orders, 28 U.S.C. § 1291 (20 12 ), and certain
interlocutory and collateral orders, 28 U.S.C. § 1292 (20 12 );

Fed. R. Civ. P. 54(b); Cohen v. Beneficial Indu s. Loan Corp. ,
337 U.S. 541 , 545

- 46 (1949). The order Smith seeks to appeal is
neither a final order nor an appealable interlocutory or
collateral order. Accordingly, we dismiss the appeal for lack
of jurisdiction. We dispense with oral argument because the
facts and legal contentions are adequately prese nted in the

materials before this court and argument would not aid the
decisional process.

DISMISSED
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.3680 Primidone test system. ( a ) *Identification.* A primidone test system is a device intended to measure primidone, an antiepileptic drug, in human specimens. Measurements obtained by this device are used in the diagnosis and treatment of primidone overdose and in monitoring levels of primidone to ensure appropriate therapy.
( b ) *Classification.* Class II.
HonorableNeil J. Gilligan CountyAuditor Uvalde County Dvalda, Texas Dear Sir: Opinion NumberO-2923 Be: Time for holding road bond elections. Ilbhave your letter of 

### Novauber23, which reads as followsr "Will you kindly informme whether or not Article 704. as amended,Vernon's ¬ated Civil Statutes, providing bond elections shall be heldnot less than 15 nor more than 30 days from the date or order of election,prevails wbr Article 2950 wherein it is stated that the munty Judge shall oausenotice of election to be posted or published for thirty days? I pm interestedin P county-widebond ale&ion - - roadbond." We first aallyour attention to ths fact that Title 22, Chapter 3,hrticles 752a, et seq., constitutethe staturotyauthority for the issuance of road bonds. Article 752f-2 reads as follows: "The Conrmissioners' Court shall determine the time and plaoe or places of holding suoh election, and ths date of such election sh4.l not be less than thirty days from the date ofmaking the order of election." This artihle refers to the election contemplatedby Article 752f,wherein it is provided that if the proposed issue of bonds and levy of taxes is for tt7 e&ire county, notice of election shallbegiven by publioation In a newsgaper published,in such county for three successiveweeks, if there be one, and futiher provides that in addition thereto for P period of three meks prior to said election,notice shall be postedby the county olerk & four public plaoes in the county, one of whioh shall ba at the oounty courthousedoor..

HonorableNeil J. Gilligan - Page 2 (O-2923)

followsr 1c,call your attention to Article 752g, which reads as

"Themanner of holding such sleotion and canvassing andmaking returns thereof shall be governed by the general laws of this Statewhen not in confliotwith the provisions of this Act." We ara of the opinion that the issuanoeof road bonds and the manner of voting samemust be in rccordanoewith the above quoted articles, and that &tic10 704, as amended, and 2950, referred to in your latter,have no application in the isauanoe of such bonds.

You PI-~,

therefore, advised that in any road bond election, notice thereof shall bsposted for P period of not less than thirty days from the date, of the order of election. Trusting that the foregoing satisfactorilyanswersyour inquip, we *rb Yours very truly

CEC-srEGW APFROVED DEC 17, 1940 /s/ Gerald C. Mann ATTORNEYGEIWRALOFTEXAS ATTORNEY GIiXERAL OF TE#S
By /*/ Cl~rsncs E. Crowa

Clarence E. Crowe

Assistant

Approved Opinion Committee By BKB Chairman
Editorial Note on Part 882
Editorial Note: Nomenclature changes to part 882 appear at 73 FR 35341, June 23, 2008.

§ 882.5896 Percutaneous nerve stimulator for substance use disorders. ( a ) *Identification.* A percutaneous nerve stimulator for substance use disorders is a device that stimulates nerves percutaneously to aid in the reduction of withdrawal symptoms associated with substance use disorders.
( b ) *Classification.* Class II (special controls). The special controls for this device are: ( 1 ) The patient-contacting components of the device must be demonstrated to be biocompatible.
( 2 ) Electromagnetic compatibility and electrical, mechanical, and thermal safety testing must be performed.
( 3 ) Electrical performance testing of the device and electrodes must be conducted to validate the specified electrical output and duration of stimulation of the device.
( 4 ) Software verification, validation, and hazard analysis must be performed.
( 5 ) Sterility testing of the percutaneous components of the device must be performed.
( 6 ) Shelf life testing must be performed to demonstrate continued sterility, package integrity, and device functionality over the specified shelf life.
( 7 ) Labeling must include the following: ( i ) A detailed summary of the device technical parameters;
( ii ) A warning stating that the device is only for use on clean, intact skin;
( iii ) Instructions for use, including placement of the device on the patient; and
( iv ) A shelf life.
[83 FR 5034, Feb. 5, 2018]
Exhibit 31.b

I, Marc Teal, certify that:

1.		I have reviewed this quarterly report on Form 10-Q of American Affordable Housing II Limited Partnership (the "Partnership");

Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this quarterly report;

The Partnership's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the Company and we have:

designed such disclosure controls and procedures to ensure that material information relating to the Partnership, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

evaluated the effectiveness of the Partnership's disclosure controls and procedures as of a date (the "Evaluation Date") within 45 days prior to the filing date of this quarterly report; and

presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

The Partnership's other certifying officer and I have disclosed, based on our most recent evaluation, to the Partnership's auditors and the audit committee of the Partnership's board of directors (or persons performing the equivalent function):

all significant deficiencies in the design or operation of internal controls which could adversely affect the Partnership's ability to record, process, summarize and report financial data and have identified for the Partnership's auditors any material weaknesses in internal controls; and

any fraud, whether or not material, that involves management or other employees who have a significant role in the Partnership's internal controls; and

The Partnership's other certifying officer and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the Evaluation Date, including any corrective actions with regard to significant deficiencies and material weaknesses.